Title:
【発明の名称】肝硬変治療剤
Document Type and Number:
Japanese Patent JP2784455
Kind Code:
B2
Abstract:
A therapeutic agent for hepatocirrhosis containing a hepatocyte growth factor as an active ingredient. Since the hepatocyte growth factor suppresses fiber formation and simultaneously stimulates hepatocyte proliferation, it is considered to be effective for preventing the transition from chronic hepatitis to hepatocirrhosis and progress of hepatocirrhosis, and also for the treatment of considerably advanced hepatocirrhosis and other hepatic diseases such as hepatitis.
Inventors:
NAKAMURA TOSHIICHI
Application Number:
JP11903090A
Publication Date:
August 06, 1998
Filing Date:
May 09, 1990
Export Citation:
Assignee:
NAKAMURA TOSHIICHI
International Classes:
A61K38/00; A61K38/22; A61P1/16; A61P43/00; C07K14/475; (IPC1-7): A61K38/22; A61K38/22
Domestic Patent References:
| JP6245530A |
Other References:
Ｎａｔｕｒａ，Ｖｏｌ．３４２（１９８９），Ｐ．４４０−４４３
Attorney, Agent or Firm:
Hiromi Hirose